Developer docs
API playgroundTry for free, no card

Search company profiles

Hargreave Hale Aim VCT

Full company profile

uuid0007o8o

Namestring
Hargreave Hale Aim VCT
Legal namestring
Hargreave Hale AIM VCT plc
Company typeenum
Public
Founded yearint
2004
Descriptiontext

Hargreave Hale AIM VCT plc is a UK Venture Capital Trust incorporated in England and Wales (company no. 05206425) in 2004 and listed on the London Stock Exchange Main Market under ticker HHV. It invests in a diversified portfolio of small, high-growth UK companies — primarily those quoted on AIM, supplemented by qualifying private companies — across sectors including life sciences, technology, industrials, consumer discretionary, defence and materials. As at the latest period, the qualifying portfolio comprised 54 companies, of which 17 had been held for more than 10 years, and portfolio holdings had a weighted average 3-year revenue CAGR of 19.8% with average revenues of approximately £58m and average profits of approximately £4.3m per company.

The VCT is managed under a discretionary investment management agreement by Canaccord Genuity Asset Management Limited (FCA reference 209741), which receives a 3.5% fee on gross proceeds from subscription offers plus ongoing asset-based management fees; marketing materials are approved by Canaccord Genuity Wealth Limited (FCA reference 194927). The dedicated investment team of four professionals — lead manager Oliver Bedford, co-manager Lucy Bloomfield, portfolio manager Anna Salim, and one additional professional — is supported by nine further fund managers and analysts within Canaccord's wider £1.95bn AUM team. In January 2026 the VCT launched a £20m offer for subscription with a £10m over-allotment facility, following UK Budget changes that increased funding limits for VCT-qualifying companies.

The product targets two end-customers: UK-resident individual investors seeking HMRC-approved tax reliefs (upfront 20-30% income tax relief, tax-free dividends, capital gains tax exemption subject to a five-year minimum hold), and the financial advisers/wealth managers who distribute the VCT to those clients. Capital is raised through periodic public offers and LSE secondary trading, with liquidity reinforced by a regular share buyback policy, a Dividend Re-investment Scheme (DRIS), and quarterly NAV disclosure. Recent portfolio activity includes a £2.5m lead investment in Qureight (Series A, April 2024), participation in LabGenius Therapeutics' £35m Series B extension (February 2026), and a £1.5m investment in Xampla (Series A, April 2026), alongside £8.2m deployed across four new qualifying investments in H1 FY26.

Short descriptiontext

Hargreave Hale AIM VCT is a UK-listed Venture Capital Trust investing in a diversified portfolio of small, high-growth UK companies, primarily AIM-listed. It offers UK individual investors and IFAs HMRC-approved tax-efficient exposure to early-stage UK equities, managed by Canaccord Genuity Asset Management.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital trust, AIM-listed investments, UK small-cap equity, tax-efficient investments, growth capital
Industry2 codes
1Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryYes
2Micro-VC & Angel Funds
CodeFSANAAAIPrimaryNo
NAICS code1 code
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investors, Nec6799
Product category
Venture Capital Trust
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment management fees
TypeSubscription Recurring
Description

Canaccord Genuity Asset Management Limited acts as investment manager and administrator, receiving a fee of 3.5% of gross proceeds from share offers (constituting a related party transaction under FCA Listing Rules). Ongoing management fees are charged on assets under management. These fees constitute the primary revenue stream supporting the VCT's operations.

hargreaveaimvcts.co.uk
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Standard offer tier
ModelSubscriptionBilling cadenceOne time/ perpetual license
Notes

Target raise of £20m with £10m over-allotment; 3.5% fee on gross proceeds to investment manager; 20% income tax relief for investors (subject to eligibility and holding period)

hargreaveaimvcts.co.uk
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Hargreave Hale AIM VCT is a publicly listed venture capital trust that invests in a diversified portfolio of high-growth, small UK companies, primarily those listed on the Alternative Investment Market (AIM) along with select private companies. It provides UK investors with tax-efficient exposure to small-cap UK equities through HMRC-approved VCT status, offering upfront income tax relief (20-30%), tax-free dividends, and capital gains tax exemption, subject to a minimum five-year holding period. The VCT is managed by Canaccord Genuity Asset Management Limited and listed on the London Stock Exchange Main Market.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 19.8% weighted average 3-year revenue CAGR for VCT qualifying companies in portfolio
+3 more records
Product overview1 text field

Hargreave Hale AIM VCT is a single, unified venture capital trust investment product. The VCT provides tax-efficient investment opportunities in small high-growth UK companies, primarily listed on AIM but also including private companies. The offering combines a diversified investment portfolio with HMRC-approved tax benefits including upfront income tax relief (30% reducing to 20% from April 2026), tax-free dividends, and capital gains tax exemption. The product is supported by a Dividend Re-investment Scheme (DRIS) for shareholders wishing to reinvest dividends, and a regular share buyback policy providing liquidity. The VCT has a 20+ year track record since inception in 2004 and manages a qualifying portfolio of 54 high-growth companies across sectors including life sciences, technology, industrials, and consumer discretionary.

Product and service4 records
1Hargreave Hale AIM VCT
Categoryventure capital trust
Description

An HMRC-approved venture capital trust providing UK investors with tax-efficient exposure to a diversified portfolio of 54 high-growth small UK companies (primarily AIM-listed), offering upfront income tax relief, tax-free dividends, and capital gains tax exemption for a minimum five-year holding period.

22026 Share Offer (£20 million)
Categoryshare offer for subscription
Description

A share subscription offer launched in January 2026 to raise up to £20 million (with a £10 million over-allotment facility) from new investors, offering upfront income tax relief on subscriptions subject to eligibility and a minimum five-year holding requirement.

3Dividend Re-investment Scheme (DRIS)
Categoryshareholder reinvestment scheme
Description

A dividend reinvestment scheme allowing shareholders to reinvest cash dividends into purchasing additional ordinary shares in the VCT, which attracts income tax relief, supporting compound growth for long-term investors.

4Share Buyback Policy
Categoryliquidity programme
Description

A regular share buyback programme that purchases the VCT's own shares in the market for cancellation at periodic intervals, providing liquidity for shareholders wishing to exit before realising value through secondary market sale.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Canaccord Genuity Asset Management Limited acts as the investment manager and administrator of Hargreave Hale AIM VCT plc, authorised and regulated by the FCA (reference number 209741). CGAML is supported by Canaccord Genuity Wealth Limited (CGWL), which acts as custodian and approves marketing material. CGWL is also authorised and regulated by the FCA (reference number 194927). Both entities are part of Canaccord Genuity Group Inc. The investment manager fee is 3.5% of gross proceeds from share offers.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest UK AIM-focused venture capital trusts, also investing primarily in AIM-listed qualifying companies for retail investors with similar VCT tax reliefs. Direct competitor for retail flow, IFA distribution, and deal flow across UK small-cap companies.

TypeDirect peer
Description

UK VCT focused on smaller and faster-growing UK companies listed on AIM and elsewhere. Direct competitor for UK small-cap deal flow and VCT-allocated investor capital, with overlapping investment themes in regional and growth-stage UK businesses.

TypeDirect peer
Description

UK venture capital trust investing in qualifying early-stage and growth companies, with a strong technology focus. Direct peer for both fundraising and deal flow, particularly in UK knowledge-intensive companies within the same HMRC VCT framework.

TypeDirect peer
Description

Long-established UK VCT investing in technology and general qualifying companies. Direct competitor for VCT retail capital and UK small-cap deal flow, with a similarly diversified portfolio approach across sectors.

TypeDirect peer
Description

UK VCT managed by YFM Equity Partners investing in smaller UK growth companies. Direct peer in the VCT segment with overlapping mandate on UK small-cap qualifying companies and similar IFA-led distribution.

TypeDirect peer
Description

UK VCT focused on growth-stage qualifying companies including AIM-listed businesses. Direct peer for fundraising, retail/I FA distribution, and deal-flow competition in the UK small-cap growth segment.

TypeDirect peer
Description

UK investment trust (operating under similar tax-advantaged structures historically) investing in unquoted small and medium-sized UK companies. Comparable in mandate and end-investor base to Hargreave Hale AIM VCT.

TypeDirect peer
Description

UK VCT managed by Living Bridge investing in smaller UK growth companies across sectors. Direct competitor in the VCT retail market and for IFA-led distribution into UK small-cap qualifying holdings.

TypeBroad incumbent
Description

Listed UK investment trust focused on UK smaller companies; a broader incumbent in the UK small-cap investment space, providing investors with a more liquid alternative to VCTs that competes for similar end-client allocations.

TypeBroad incumbent
Description

Large, well-established UK investment trust investing in smaller UK quoted companies. A broader incumbent offering UK small-cap exposure with greater liquidity than VCTs, competing for the same pool of UK growth-oriented capital.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment7 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hargreave Hale Aim VCT

Venture Capital Trusthargreaveaimvcts.co.uk

Hargreave Hale AIM VCT is a UK-listed Venture Capital Trust investing in a diversified portfolio of small, high-growth UK companies, primarily AIM-listed. It offers UK individual investors and IFAs HMRC-approved tax-efficient exposure to early-stage UK equities, managed by Canaccord Genuity Asset Management.

What Hargreave Hale Aim VCT does

Hargreave Hale AIM VCT plc is a UK Venture Capital Trust incorporated in England and Wales (company no. 05206425) in 2004 and listed on the London Stock Exchange Main Market under ticker HHV. It invests in a diversified portfolio of small, high-growth UK companies — primarily those quoted on AIM, supplemented by qualifying private companies — across sectors including life sciences, technology, industrials, consumer discretionary, defence and materials. As at the latest period, the qualifying portfolio comprised 54 companies, of which 17 had been held for more than 10 years, and portfolio holdings had a weighted average 3-year revenue CAGR of 19.8% with average revenues of approximately £58m and average profits of approximately £4.3m per company.

The VCT is managed under a discretionary investment management agreement by Canaccord Genuity Asset Management Limited (FCA reference 209741), which receives a 3.5% fee on gross proceeds from subscription offers plus ongoing asset-based management fees; marketing materials are approved by Canaccord Genuity Wealth Limited (FCA reference 194927). The dedicated investment team of four professionals — lead manager Oliver Bedford, co-manager Lucy Bloomfield, portfolio manager Anna Salim, and one additional professional — is supported by nine further fund managers and analysts within Canaccord's wider £1.95bn AUM team. In January 2026 the VCT launched a £20m offer for subscription with a £10m over-allotment facility, following UK Budget changes that increased funding limits for VCT-qualifying companies.

The product targets two end-customers: UK-resident individual investors seeking HMRC-approved tax reliefs (upfront 20-30% income tax relief, tax-free dividends, capital gains tax exemption subject to a five-year minimum hold), and the financial advisers/wealth managers who distribute the VCT to those clients. Capital is raised through periodic public offers and LSE secondary trading, with liquidity reinforced by a regular share buyback policy, a Dividend Re-investment Scheme (DRIS), and quarterly NAV disclosure. Recent portfolio activity includes a £2.5m lead investment in Qureight (Series A, April 2024), participation in LabGenius Therapeutics' £35m Series B extension (February 2026), and a £1.5m investment in Xampla (Series A, April 2026), alongside £8.2m deployed across four new qualifying investments in H1 FY26.

Hargreave Hale Aim VCT firmographics

Firmographics
Name
Hargreave Hale Aim VCT
Legal name
Hargreave Hale AIM VCT plc
Website
https://hargreaveaimvcts.co.uk
Company type
Public
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Hargreave Hale AIM VCT is a UK-listed Venture Capital Trust investing in a diversified portfolio of small, high-growth UK companies, primarily AIM-listed. It offers UK individual investors and IFAs HMRC-approved tax-efficient exposure to early-stage UK equities, managed by Canaccord Genuity Asset Management.
Ownership category
akta.pro rank

Hargreave Hale Aim VCT industry classification

Industry
Product category
Venture Capital Trust
NAICS
Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investors, Nec (6799)
akta.pro primary industry
Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
akta.pro secondary industry
Micro-VC & Angel Funds (FSANAAAI)

Keywords

  • Venture capital trust
  • AIM-listed investments
  • UK small-cap equity
  • Tax-efficient investments
  • Growth capital

Where Hargreave Hale Aim VCT is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Hargreave Hale Aim VCT business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Investment management fees: Canaccord Genuity Asset Management Limited acts as investment manager and administrator, receiving a fee of 3.5% of gross proceeds from share offers (constituting a related party transaction under FCA Listing Rules). Ongoing management fees are charged on assets under management. These fees constitute the primary revenue stream supporting the VCT's operations.

Pricing tiers

ModelBillingPrice
SubscriptionOne time/ perpetual licenseStandard offer tier

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Hargreave Hale Aim VCT product offering

Product offering

Core offering

Hargreave Hale AIM VCT is a publicly listed venture capital trust that invests in a diversified portfolio of high-growth, small UK companies, primarily those listed on the Alternative Investment Market (AIM) along with select private companies. It provides UK investors with tax-efficient exposure to small-cap UK equities through HMRC-approved VCT status, offering upfront income tax relief (20-30%), tax-free dividends, and capital gains tax exemption, subject to a minimum five-year holding period. The VCT is managed by Canaccord Genuity Asset Management Limited and listed on the London Stock Exchange Main Market.

Product overview

Hargreave Hale AIM VCT is a single, unified venture capital trust investment product. The VCT provides tax-efficient investment opportunities in small high-growth UK companies, primarily listed on AIM but also including private companies. The offering combines a diversified investment portfolio with HMRC-approved tax benefits including upfront income tax relief (30% reducing to 20% from April 2026), tax-free dividends, and capital gains tax exemption. The product is supported by a Dividend Re-investment Scheme (DRIS) for shareholders wishing to reinvest dividends, and a regular share buyback policy providing liquidity. The VCT has a 20+ year track record since inception in 2004 and manages a qualifying portfolio of 54 high-growth companies across sectors including life sciences, technology, industrials, and consumer discretionary.

Differentiator

Problem solved

Functional benefit

Products and services

  • Hargreave Hale AIM VCT An HMRC-approved venture capital trust providing UK investors with tax-efficient exposure to a diversified portfolio of 54 high-growth small UK companies (primarily AIM-listed), offering upfront income tax relief, tax-free dividends, and capital gains tax exemption for a minimum five-year holding period.
  • 2026 Share Offer (£20 million) A share subscription offer launched in January 2026 to raise up to £20 million (with a £10 million over-allotment facility) from new investors, offering upfront income tax relief on subscriptions subject to eligibility and a minimum five-year holding requirement.
  • Dividend Re-investment Scheme (DRIS) A dividend reinvestment scheme allowing shareholders to reinvest cash dividends into purchasing additional ordinary shares in the VCT, which attracts income tax relief, supporting compound growth for long-term investors.
  • Share Buyback Policy A regular share buyback programme that purchases the VCT's own shares in the market for cancellation at periodic intervals, providing liquidity for shareholders wishing to exit before realising value through secondary market sale.

Quantifiable outcome

  • 19.8% weighted average 3-year revenue CAGR for VCT qualifying companies in portfolio
  • +3 more outcomes

Companies that use Hargreave Hale Aim VCT

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Hargreave Hale Aim VCT technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Hargreave Hale Aim VCT partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Canaccord Genuity Asset Management Limited (CGAML)coreImplementation/ SI/ Consulting PartnerCanaccord Genuity Asset Management Limited acts as the investment manager and administrator of Hargreave Hale AIM VCT plc, authorised and regulated by the FCA (reference number 209741). CGAML is supported by Canaccord Genuity Wealth Limited (CGWL), which acts as custodian and approves marketing material. CGWL is also authorised and regulated by the FCA (reference number 194927). Both entities are part of Canaccord Genuity Group Inc. The investment manager fee is 3.5% of gross proceeds from share offers.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Hargreave Hale Aim VCT competitors and assessment

Company assessment

Direct peers

  • Octopus AIM VCT: One of the largest UK AIM-focused venture capital trusts, also investing primarily in AIM-listed qualifying companies for retail investors with similar VCT tax reliefs. Direct competitor for retail flow, IFA distribution, and deal flow across UK small-cap companies.
  • Maven Income and Growth VCT: UK VCT focused on smaller and faster-growing UK companies listed on AIM and elsewhere. Direct competitor for UK small-cap deal flow and VCT-allocated investor capital, with overlapping investment themes in regional and growth-stage UK businesses.
  • Foresight Williams VCT: UK venture capital trust investing in qualifying early-stage and growth companies, with a strong technology focus. Direct peer for both fundraising and deal flow, particularly in UK knowledge-intensive companies within the same HMRC VCT framework.
  • Albion Technology & General VCT: Long-established UK VCT investing in technology and general qualifying companies. Direct competitor for VCT retail capital and UK small-cap deal flow, with a similarly diversified portfolio approach across sectors.
  • British Smaller Companies VCT: UK VCT managed by YFM Equity Partners investing in smaller UK growth companies. Direct peer in the VCT segment with overlapping mandate on UK small-cap qualifying companies and similar IFA-led distribution.
  • Downing FOUR VCT: UK VCT focused on growth-stage qualifying companies including AIM-listed businesses. Direct peer for fundraising, retail/I FA distribution, and deal-flow competition in the UK small-cap growth segment.
  • Northern Investors Company: UK investment trust (operating under similar tax-advantaged structures historically) investing in unquoted small and medium-sized UK companies. Comparable in mandate and end-investor base to Hargreave Hale AIM VCT.
  • Baronsmead VCT: UK VCT managed by Living Bridge investing in smaller UK growth companies across sectors. Direct competitor in the VCT retail market and for IFA-led distribution into UK small-cap qualifying holdings.

Broad incumbents

  • Montanaro UK Smaller Companies Investment Trust: Listed UK investment trust focused on UK smaller companies; a broader incumbent in the UK small-cap investment space, providing investors with a more liquid alternative to VCTs that competes for similar end-client allocations.
  • BlackRock Smaller Companies Trust: Large, well-established UK investment trust investing in smaller UK quoted companies. A broader incumbent offering UK small-cap exposure with greater liquidity than VCTs, competing for the same pool of UK growth-oriented capital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Hargreave Hale Aim VCT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hargreave Hale Aim VCT leadership team

Management profile

Number of profiles

Profiles3 records

Hargreave Hale Aim VCT funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hargreave Hale Aim VCT M&A and investment

M&A and investment

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hargreave Hale Aim VCT

What does Hargreave Hale Aim VCT do?

Hargreave Hale AIM VCT is a publicly listed venture capital trust that invests in a diversified portfolio of high-growth, small UK companies, primarily those listed on the Alternative Investment Market (AIM) along with select private companies. It provides UK investors with tax-efficient exposure to small-cap UK equities through HMRC-approved VCT status, offering upfront income tax relief (20-30%), tax-free dividends, and capital gains tax exemption, subject to a minimum five-year holding period. The VCT is managed by Canaccord Genuity Asset Management Limited and listed on the London Stock Exchange Main Market.

Is Hargreave Hale Aim VCT a public or private company?

Hargreave Hale Aim VCT is a public company. It is classified as public and is currently operating.

When was Hargreave Hale Aim VCT founded?

Hargreave Hale Aim VCT was founded in 2004. It employs 11 to 50 people.

Where is Hargreave Hale Aim VCT based?

Hargreave Hale Aim VCT is headquartered in London, United Kingdom, in the Europe region.

How does Hargreave Hale Aim VCT make money?

One revenue line is on record: investment management fees.

Who are Hargreave Hale Aim VCT's main competitors?

Direct peers on record are Octopus AIM VCT, Maven Income and Growth VCT, Foresight Williams VCT, Albion Technology & General VCT, British Smaller Companies VCT, Downing FOUR VCT, Northern Investors Company and Baronsmead VCT. Broad incumbents are Montanaro UK Smaller Companies Investment Trust and BlackRock Smaller Companies Trust.

Does Hargreave Hale Aim VCT have an API?

No public API is recorded for Hargreave Hale Aim VCT.

What industry is Hargreave Hale Aim VCT in?

Hargreave Hale Aim VCT's product category is Venture Capital Trust. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANAAAI, Micro-VC & Angel Funds. Its NAICS code is 525 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InvestegateAdmission of Further Shares to TradingHargreave Hale AIM VCT admitted 990,800 new ordinary shares to trading on the London Stock Exchange on 7 October 2026, following an allotment under its dividend reinvestment scheme. The admission brings the total number of ordinary shares in issue to 375,093,640.Ticker ReportHargreave Hale AIM VCT (LON:HHV) Shares Break Above 50-Day Moving Average – What’s Next?Hargreave Hale AIM VCT shares traded above their 50-day moving average on Wednesday, reaching GBX 30. The stock's 50-day MA is GBX 29.66, and insider Justin Ward bought 1,325 shares at GBX 3,169 each. The trust has a market cap of £109.71 million and a P/E of 83.79.American Banking and Market NewsHargreave Hale AIM VCT (LON:HHV) Share Price Breaks Above 50 Day Moving Average – Should You Sell?Hargreave Hale AIM VCT shares traded above their 50-day moving average on Wednesday, reaching GBX 30 from a 50-day average of GBX 29.66. Insider Justin Ward bought 1,325 shares at GBX 3,169 each, and the company's market cap is £111.75 million with a PE ratio of 85.34.Investing.comStock Market News - Investing.com IndiaHargreave Hale AIM VCT appointed Duncan John Neale as an independent non-executive director, effective October 1, following an external recruitment process. Neale brings over 10 years of non-executive director experience, including roles as audit committee chair and senior independent director.Investing.comLatest Company News - Investing.comHargreave Hale AIM VCT appointed Duncan John Neale as an independent non-executive director, effective October 1, following an external recruitment process. Neale brings over 10 years of non-executive director experience, including roles as audit committee chair and senior independent director.YahooAppointment of Non-Executive DirectorHargreave Hale AIM VCT appointed Duncan John Neale as an independent non-executive director, effective 1 October 2026, following an external recruitment process. Neale brings over a decade of non-executive experience, including roles as Audit Committee Chair and CFO. The appointment is made pursuant to UKLR 6.4.6R.InvestegateAllotment of Shares under DRISHargreave Hale AIM VCT PLC allotted 990,800 ordinary shares at 31.50 pence each under its Dividend Reinvestment Scheme, representing a special dividend of 0.75 pence per share. Dealings are expected to commence around October 7, 2026, and the total number of ordinary shares in issue is now 375,295,536.InvestegateAppointment of Non-Executive DirectorHargreave Hale AIM VCT appointed Duncan John Neale as an independent non-executive director, effective 1 October 2026. He brings over a decade of non-executive experience, including chairing audit and risk committees, and previously served as CFO for listed and private companies.StartupmagBiotech 52North raises £3.2m led by Macmillan Ventures with Hargreave Hale AIM VCT52North, a Cambridge spin-out, raised £3.2m in grant funding led by Macmillan Ventures to advance clinical validation and regulatory progress for Neutrocheck, a rapid finger-prick test for triaging chemotherapy patients at risk of neutropenic sepsis. The round brings total equity raised to over £7.5m, with Hargreave Hale AIM VCT joining as a new investor.52North52North raises £3.2 million to transform urgent cancer care, with funding co-led by Macmillan Cancer Support and Hargreave Hale AIM VCT52North raised £3.2 million to accelerate Neutrocheck, a finger-prick test for chemotherapy patients at risk of neutropenic sepsis. The round, co-led by Macmillan Ventures and Hargreave Hale AIM VCT, brings total equity funding to over £7.5 million. The funding will support clinical validation and regulatory progression for the UK market launch.